Estee Lauder and Puig: Merger a Boost to Fragrance Portfolio, but Challenging in Size and Timing

On March 23, Estee Lauder confirmed that it is in talks with Puig about a potential merger but did not offer details. Shares of Estee Lauder fell 8% during trading hours after The Wall Street Journal and Financial Times reported on the potential deal.

Why it matters: If completed, a Puig merger would lift Estee’s market share in premium fragrance to 15% from 6% (per Euromonitor), second only to L’Oreal’s 16%. However, we see challenges from the deal size and its potential to distract Estee’s management amid a turnaround.

• Given Puig’s USD 10 billion market cap, the potential merger is significantly larger than Estee’s prior largest deal, its USD 2.8 billion acquisition of Tom Ford in 2023. We are skeptical that Estee’s management can execute such a large merger in a way that creates shareholder value.
• Moreover, Estee is in the middle of a multiyear turnaround, which requires management to focus on brand investments, innovation, and in-market execution after three years of sales declines. We doubt that management can execute this plan efficiently while integrating Puig.

The bottom line: Since the merger has not been finalized, we maintain our fair value estimates of USD 120 for wide-moat Estee Lauder and EUR 22 for no-moat Puig. Shares of Estee and Puig trade at respective discounts of 34% and 29% to our fair value estimates.

• If a merger occurs, a combined firm would have roughly USD 20 billion in sales and a 17% EBITDA margin. We see some efficiency gains in fragrance manufacturing, but expect little margin lift in Estee’s core skin care (half of sales), given Puig’s small sales (USD 0.6 billion) in the category.
• While Estee can raise its net leverage from 2.6 times and tap its USD 1.5 billion in projected 2026 free cash flow, it may need to issue up to USD 6 billion in new shares (about 20% of its current USD 29 billion market cap) to fund the deal, likely putting shares under further pressure.